Payments to Acquire Property, Plant, and Equipment in USD of Poseida Therapeutics, Inc. from 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Poseida Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2019 to Q1 2024.
  • Poseida Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $130K, a 83.4% decline year-over-year.
  • Poseida Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $3.07M, a 21.9% decline from 2022.
  • Poseida Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $3.92M, a 49% increase from 2021.
  • Poseida Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $2.63M, a 84.4% decline from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

Poseida Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $130K -$654K -83.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $784K +$41K +5.52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $743K +$268K +56.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $475K -$3.04M -86.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $3.52M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11

Poseida Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.07M -$858K -21.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $3.92M +$1.29M +49% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $2.63M -$14.3M -84.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $16.9M +$11.8M +228% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $5.16M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.